COVID-19 Pandemic which started in 2019 is probably getting into its last phases as third wave hits India in December 2020-January 2021. Thankfully now we have got two oral drugs against SARS-CoV2 virus which is responible for COVID-19 diseases. So far as per our experience the latest variant of SARS-CoV2, aka Omnicron is the causative agent in the third wave.
America's drug controller FDA (Food and Drug Administration) has approved these two anti-COVID oral antivirals as Emergency Use Authorization (EUA) - Molnupiravir and Paxlovid.
